KIFLE JIKAMO: Open Payments
NPI 1811670615 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 2 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $251 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $141 |
| Neurocrine BioSciences, Inc. | 1 | $119 |
Products named: CAPLYTA, INGREZZA.
Industry payments across CA — which companies pay providers there.
